The DOI matches its Crossref record; 389 of the 389 references it cites were found in a registry or an index.
Post‐translational modifications of histones: Mechanisms, biological functions, and therapeutic targets
Open accessAbstract
Histones are DNA‐binding basic proteins found in chromosomes. After the histone translation, its amino tail undergoes various modifications, such as methylation, acetylation, phosphorylation, ubiquitination, malonylation, propionylation, butyrylation, crotonylation, and lactylation, which together constitute the “histone code.” The relationship between their combination and biological function can be used as an important epigenetic marker. Methylation and demethylation of the same histone residue, acetylation and deacetylation, phosphorylation and dephosphorylation, and even methylation and acetylation between different histone residues cooperate or antagonize with each other, forming a complex network. Histone‐modifying enzymes, which cause numerous histone codes, have become a hot topic in the research on cancer therapeutic targets. Therefore, a thorough understanding of the role of histone post‐translational modifications (PTMs) in cell life activities is very important for preventing and treating human diseases. In this review, several most thoroughly studied and newly discovered histone PTMs are introduced. Furthermore, we focus on the histone‐modifying enzymes with carcinogenic potential, their abnormal modification sites in various tumors, and multiple essential molecular regulation mechanism. Finally, we summarize the missing areas of the current research and point out the direction of future research. We hope to provide a comprehensive understanding and promote further research in this field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21654 · Cited by 16,522
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0155 · Cited by 7,094
Llovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., & Finn, R. S. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00240-3 · Cited by 7,055
Chen, X., Xiu, M., Xing, J., Yu, S., Min, D., & Guo, F. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479439 · Cited by 5,742
Metabolic regulation of gene expression by histone lactylation
Zhang, D., Tang, Z., Huang, H., Zhou, G., Cui, C., Weng, Y., Liu, W., Kim, S., Lee, S., Perez-Neut, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1678-1 · Cited by 4,371
Lysine acetylation targets protein complexes and co-regulates major cellular functions
Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., & Mann, M. (2009) · Science · doi:10.1126/science.1175371 · Cited by 4,040
Cancer epigenetics: from mechanism to therapy
Dawson, M. A., & Kouzarides, T. (2012) · Cell · doi:10.1016/j.cell.2012.06.013 · Cited by 3,203
Molecular mechanisms of cisplatin resistance
Galluzzi, L., Senovilla, L., Vitale, I., Michels, J., Martins, I., Kepp, O., Castedo, M., & Kroemer, G. (2012) · Oncogene · doi:10.1038/onc.2011.384 · Cited by 2,760
ACETYLATION AND METHYLATION OF HISTONES AND THEIR POSSIBLE ROLE IN THE REGULATION OF RNA SYNTHESIS
Allfrey, V. G., Faulkner, R., & Mirsky, A. E. (1964) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.51.5.786 · Cited by 2,639
Histone methylation: a dynamic mark in health, disease and inheritance
Greer, E. L., & Shi, Y. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3173 · Cited by 2,241
Tan, M., Luo, H., Lee, S., Jin, F., Yang, J. S., Montellier, E., Buchou, T., Cheng, Z., Rousseaux, S., Rajagopal, N., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.008 · Cited by 1,902
Cisplatin: The first metal based anticancer drug
Ghosh, S. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.102925 · Cited by 1,751
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Ajani, J. A., D’Amico, T. A., Bentrem, D. J., Chao, J., Cooke, D., Corvera, C., Das, P., Enzinger, P. C., Enzler, T., Fanta, P., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0008 · Cited by 1,684
Kim, K. H., & Roberts, C. W. M. (2016) · Nature Medicine · doi:10.1038/nm.4036 · Cited by 1,471
Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase
Du, J., Zhou, Y., Su, X., Yu, J. J., Khan, S., Jiang, H., Kim, J., Woo, J., Kim, J. H., Choi, B. H., et al. (2011) · Science · doi:10.1126/science.1207861 · Cited by 1,429
Epithelial ovarian cancer: Evolution of management in the era of precision medicine
Lheureux, S., Braunstein, M., & Oza, A. M. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21559 · Cited by 1,423
HDACs and HDAC Inhibitors in Cancer Development and Therapy
Li, Y., & Seto, E. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026831 · Cited by 1,284
-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin
Kinner, A., Wu, W., Staudt, C., & Iliakis, G. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn550 · Cited by 1,256
Functions and mechanisms of non-histone protein acetylation
Narita, T., Weinert, B. T., & Choudhary, C. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0081-3 · Cited by 1,232
Cellular Memory and the Histone Code
Turner, B. M. (2002) · Cell · doi:10.1016/s0092-8674(02)01080-2 · Cited by 1,142
Yang, X.-J., & Seto, E. (2007) · Oncogene · doi:10.1038/sj.onc.1210599 · Cited by 940
Yu, J., Chai, P., Xie, M., Ge, S., Ruan, J., Fan, X., & Jia, R. (2021) · Genome Biology · doi:10.1186/s13059-021-02308-z · Cited by 940
de Napoles, M., Mermoud, J. E., Wakao, R., Tang, Y. A., Endoh, M., Appanah, R., Nesterova, T. B., Silva, J., Otte, A. P., Vidal, M., et al. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.10.005 · Cited by 888
Pan, R.-Y., He, L., Zhang, J., Liu, X., Liao, Y., Gao, J., Liao, Y., Yan, Y., Li, Q., Zhou, X., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.02.013 · Cited by 862
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
Lasko, L. M., Jakob, C. G., Edalji, R. P., Qiu, W., Montgomery, D., Digiammarino, E. L., Hansen, T. M., Risi, R. M., Frey, R., Manaves, V., et al. (2017) · Nature · doi:10.1038/nature24028 · Cited by 858
Role of Bmi-1 and Ring1A in H2A Ubiquitylation and Hox Gene Silencing
Cao, R., Tsukada, Y.-I., & Zhang, Y. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.12.002 · Cited by 857
Class I histone deacetylases (HDAC1–3) are histone lysine delactylases
Moreno-Yruela, C., Zhang, D., Wei, W., Bæk, M., Liu, W., Gao, J., Danková, D., Nielsen, A. L., Bolding, J. E., Yang, L., et al. (2022) · Science Advances · doi:10.1126/sciadv.abi6696 · Cited by 841
Metabolic reprogramming and epigenetic modifications on the path to cancer
Sun, L., Zhang, H., & Gao, P. (2022) · Protein & Cell · doi:10.1007/s13238-021-00846-7 · Cited by 770
Self-citationLysine propionylation and butyrylation are novel post-translational modifications in histones
Chen, Y., Sprung, R., Tang, Y., Ball, H., Sangras, B., Kim, S. C., Falck, J. R., Peng, J., Gu, W., & Zhao, Y. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700021-mcp200 · Cited by 764
The first identification of lysine malonylation substrates and its regulatory enzyme
Peng, C., Lu, Z., Xie, Z., Cheng, Z., Chen, Y., Tan, M., Luo, H., Zhang, Y., He, W., Yang, K., et al. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.012658 · Cited by 751
Distinct features of H3K4me3 and H3K27me3 chromatin domains in pre-implantation embryos
Liu, X., Wang, C., Liu, W., Li, J., Li, C., Kou, X., Chen, J., Zhao, Y., Gao, H., Wang, H., et al. (2016) · Nature · doi:10.1038/nature19362 · Cited by 746
Potent inhibition of DOT1L as treatment of MLL-fusion leukemia
Daigle, S. R., Olhava, E. J., Therkelsen, C. A., Basavapathruni, A., Jin, L., Boriack-Sjodin, P. A., Allain, C. J., Klaus, C. R., Raimondi, A., Scott, M. P., et al. (2013) · Blood · doi:10.1182/blood-2013-04-497644 · Cited by 722
Histone deacetylase inhibitors: Potential in cancer therapy
Marks, P. A., & Xu, W. ‐. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22185 · Cited by 712
Epigenetics in health and disease
Zhang, L., Lu, Q., & Chang, C. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-15-3449-2_1 · Cited by 689
HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics
Gallinari, P., Marco, S. D., Jones, P., Pallaoro, M., & Steinkühler, C. (2007) · Cell Research · doi:10.1038/sj.cr.7310149 · Cited by 678
Intracellular Crotonyl-CoA Stimulates Transcription through p300-Catalyzed Histone Crotonylation
Sabari, B. R., Tang, Z., Huang, H., Yong-Gonzalez, V., Molina, H., Kong, H. E., Dai, L., Shimada, M., Cross, J. R., Zhao, Y., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.02.029 · Cited by 659
Acute myeloid leukemia: Epidemiology and etiology
Deschler, B., & Lübbert, M. (2006) · Cancer · doi:10.1002/cncr.22233 · Cited by 646
Writers and Readers of Histone Acetylation: Structure, Mechanism, and Inhibition
Marmorstein, R., & Zhou, M.-M. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a018762 · Cited by 638
Histone phosphorylation: A chromatin modification involved in diverse nuclear events
Rossetto, D., Avvakumov, N., & Côté, J. (2012) · Epigenetics · doi:10.4161/epi.21975 · Cited by 628
The regulation, functions and clinical relevance of arginine methylation
Guccione, E., & Richard, S. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0155-x · Cited by 625
Lysine succinylation and lysine malonylation in histones
Xie, Z., Dai, J., Dai, L., Tan, M., Cheng, Z., Wu, Y., Boeke, J. D., & Zhao, Y. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.015875 · Cited by 613
Chemoresistance in Pancreatic Cancer
Zeng, S., Pöttler, M., Lan, B., Grützmann, R., Pilarsky, C., & Yang, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184504 · Cited by 611
Chemically ubiquitylated histone H2B stimulates hDot1L-mediated intranucleosomal methylation
McGinty, R. K., Kim, J., Chatterjee, C., Roeder, R. G., & Muir, T. W. (2008) · Nature · doi:10.1038/nature06906 · Cited by 563
Elsheikh, S. E., Green, A. R., Rakha, E. A., Powe, D. G., Ahmed, R. A., Collins, H. M., Soria, D., Garibaldi, J. M., Paish, C. E., Ammar, A. A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3907 · Cited by 511
Epigenetic Therapies for Cancer
Bates, S. E. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1805035 · Cited by 493
Morreale, F. E., & Walden, H. (2016) · Cell · doi:10.1016/j.cell.2016.03.003 · Cited by 492
Use of the γ-H2AX assay to monitor DNA damage and repair in translational cancer research
Ivashkevich, A., Redon, C. E., Nakamura, A. J., Martin, R. F., & Martin, O. A. (2012) · Cancer Letters · doi:10.1016/j.canlet.2011.12.025 · Cited by 462
Plass, C., Pfister, S. M., Lindroth, A. M., Bogatyrova, O., Claus, R., & Lichter, P. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3554 · Cited by 453
Combining epigenetic drugs with other therapies for solid tumours — past lessons and future promise
Morel, D., Jeffery, D., Aspeslagh, S., Almouzni, G., & Postel-Vinay, S. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0267-4 · Cited by 445
A Conserved RING Finger Protein Required for Histone H2B Monoubiquitination and Cell Size Control
Hwang, W. W., Venkatasubrahmanyam, S., Ianculescu, A. G., Tong, A., Boone, C., & Madhani, H. D. (2003) · Molecular Cell · doi:10.1016/s1097-2765(02)00826-2 · Cited by 439
LSD1/KDM1A inhibitors in clinical trials: advances and prospects
Fang, Y., Liao, G., & Yu, B. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0811-9 · Cited by 438
Advances in clinical immunotherapy for gastric cancer
Li, K., Zhang, A., Li, X., Zhang, H., & Zhao, L. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188615 · Cited by 405
Self-citationTargeting histone methyltransferases and demethylases in clinical trials for cancer therapy
Morera, L., Lübbert, M., & Jung, M. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0223-4 · Cited by 395
Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy
Biswas, S., & Rao, C. M. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.08.021 · Cited by 389
Pan, L., Feng, F., Wu, J., Fan, S., Han, J., Wang, S., Yang, L., Liu, W., Wang, C., & Xu, K. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106270 · Cited by 383
Self-citationThe cancer epigenome: Concepts, challenges, and therapeutic opportunities
Dawson, M. A. (2017) · Science · doi:10.1126/science.aam7304 · Cited by 377
Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity
Griffin, G. K., Wu, J., Iracheta-Vellve, A., Patti, J. C., Hsu, J., Davis, T., Dele-Oni, D., Du, P. P., Halawi, A. G., Ishizuka, J. J., et al. (2021) · Nature · doi:10.1038/s41586-021-03520-4 · Cited by 370
Self-citationChen, M.-W., Hua, K.-T., Kao, H.-J., Chi, C.-C., Wei, L.-H., Johansson, G., Shiah, S.-G., Chen, P.-S., Jeng, Y.-M., Cheng, T.-Y., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0833 · Cited by 369
Regulation of DNA double-strand break repair by ubiquitin and ubiquitin-like modifiers
Schwertman, P., Bekker-Jensen, S., & Mailand, N. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.58 · Cited by 362
Morgan, M. A. J., & Shilatifard, A. (2020) · Nature Genetics · doi:10.1038/s41588-020-00736-4 · Cited by 355
Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma
Hanif, H., Ali, M. J., Susheela, A. T., Khan, I. W., Luna-Cuadros, M. A., Khan, M. M., & Lau, D. T.-Y. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i2.216 · Cited by 354
The MYST family of histone acetyltransferases and their intimate links to cancer
Avvakumov, N., & Côté, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210608 · Cited by 353
Histone Acetylation Enzymes Coordinate Metabolism and Gene Expression
Shen, Y., Wei, W., & Zhou, D.-X. (2015) · Trends in Plant Science · doi:10.1016/j.tplants.2015.07.005 · Cited by 352
Isoform-selective histone deacetylase inhibitors
Bieliauskas, A. V., & Pflum, M. K. H. (2008) · Chemical Society Reviews · doi:10.1039/b703830p · Cited by 350
Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy
Ramaiah, M. J., Tangutur, A. D., & Manyam, R. R. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119504 · Cited by 345
Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma
Duvic, M., & Vu, J. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.7.1111 · Cited by 344
Histone acetylation and disease
Timmermann, S., Lehrmann, H., Polesskaya, A., & Harel-Bellan, A. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000896 · Cited by 341
Hoy, S. M. (2020) · Drugs · doi:10.1007/s40265-020-01288-x · Cited by 338
Bao, X., Wang, Y., Li, X., Li, X.-M., Liu, Z., Yang, T., Wong, C. F., Zhang, J., Hao, Q., & Li, X. D. (2014) · eLife · doi:10.7554/elife.02999 · Cited by 324
Epidemiology and Etiology of Leukemia and Lymphoma
Bispo, J. A. B., Pinheiro, P. S., & Kobetz, E. K. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a034819 · Cited by 319
Leukaemogenesis: more than mutant genes
Chen, J., Odenike, O., & Rowley, J. D. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2765 · Cited by 311
The hypoxia–lactate axis tempers inflammation
Ivashkiv, L. B. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0259-8 · Cited by 305
Huang, Y., Greene, E., Murray Stewart, T., Goodwin, A. C., Baylin, S. B., Woster, P. M., & Casero, R. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700720104 · Cited by 292
Shema, E., Tirosh, I., Aylon, Y., Huang, J., Ye, C., Moskovits, N., Raver-Shapira, N., Minsky, N., Pirngruber, J., Tarcic, G., et al. (2008) · Genes & Development · doi:10.1101/gad.1703008 · Cited by 287
Posttranslational Modifications of PD-L1 and Their Applications in Cancer Therapy
Hsu, J.-M., Li, C.-W., Lai, Y.-J., & Hung, M.-C. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1892 · Cited by 286
Global Histone Modifications Predict Prognosis of Resected Non–Small-Cell Lung Cancer
Barlési, F., Giaccone, G., Gallegos-Ruiz, M. I., Loundou, A., Span, S. W., Lefesvre, P., Kruyt, F. A. E., & Rodriguez, J. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.2599 · Cited by 280
Pathological implication of protein post-translational modifications in cancer
Pan, S., & Chen, R. (2022) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2022.101097 · Cited by 263
Jiang, J., Huang, D., Jiang, Y., Hou, J., Tian, M., Li, J., Sun, L., Zhang, Y., Zhang, T., Li, Z., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.647559 · Cited by 261
Göllner, S., Oellerich, T., Agrawal-Singh, S., Schenk, T., Klein, H.-U., Rohde, C., Pabst, C., Sauer, T., Lerdrup, M., Tavor, S., et al. (2017) · Nature Medicine · doi:10.1038/nm.4247 · Cited by 257
Panobinostat for the Treatment of Multiple Myeloma
Laubach, J. P., Moreau, P., San-Miguel, J. F., & Richardson, P. G. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0530 · Cited by 255
Drug resistance in pancreatic cancer: Impact of altered energy metabolism
Grasso, C., Jansen, G., & Giovannetti, E. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.03.026 · Cited by 253
Histone 2B can be modified by the attachment of ubiquitin
West, M. H. P., & Bonner, W. M. (1980) · Nucleic Acids Research · doi:10.1093/nar/8.20.4671 · Cited by 251
Shi, Y., Jia, B., Xu, W., Li, W., Liu, T., Liu, P., Zhao, W., Zhang, H., Sun, X., Yang, H., et al. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0439-6 · Cited by 246
Self-citationEZH2-Targeted Therapies in Cancer: Hype or a Reality
Eich, M.-L., Athar, M., Ferguson, J. E., & Varambally, S. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-2147 · Cited by 242
Yang, J., Luo, L., Zhao, C., Li, X., Wang, Z., Zeng, Z., Yang, X., Zheng, X., Jie, H., Kang, L., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.73398 · Cited by 240
Self-citationOvercoming drug resistance in pancreatic cancer
Long, J., Zhang, Y., Yu, X., Yang, J., LeBrun, D. G., Chen, C., Yao, Q., & Li, M. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.566216 · Cited by 237
The Taf14 YEATS domain is a reader of histone crotonylation
Andrews, F. H., Shinsky, S. A., Shanle, E. K., Bridgers, J. B., Gest, A., Tsun, I. K., Krajewski, K., Shi, X., Strahl, B. D., & Kutateladze, T. G. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2065 · Cited by 236
Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease
Bhat, K. P., Ümit Kaniskan, H., Jin, J., & Gozani, O. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00108-x · Cited by 234
H3K18 lactylation marks tissue-specific active enhancers
Galle, E., Wong, C.-W., Ghosh, A., Desgeorges, T., Melrose, K., Hinte, L. C., Castellano-Castillo, D., Engl, M., de Sousa, J. A., Ruiz-Ojeda, F. J., et al. (2022) · Genome Biology · doi:10.1186/s13059-022-02775-y · Cited by 234
Osteosarcoma mechanobiology and therapeutic targets
Shoaib, Z., Fan, T. M., & Irudayaraj, J. M. K. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15713 · Cited by 233
Van Den Broeck, A., Brambilla, E., Moro-Sibilot, D., Lantuejoul, S., Brambilla, C., Eymin, B., Khochbin, S., & Gazzeri, S. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0869 · Cited by 232
Kim, M. Y., Woo, E. M., Chong, Y. T. E., Homenko, D. R., & Kraus, W. L. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0531 · Cited by 227
Belayneh, R., Fourman, M. S., Bhogal, S., & Weiss, K. R. (2021) · Current Oncology Reports · doi:10.1007/s11912-021-01053-7 · Cited by 223
YEATS2 is a selective histone crotonylation reader
Zhao, D., Guan, H., Zhao, S., Mi, W., Wen, H., Li, Y., Zhao, Y., Allis, C. D., Shi, X., & Li, H. (2016) · Cell Research · doi:10.1038/cr.2016.49 · Cited by 220
Munshi, A., Tanaka, T., Hobbs, M. L., Tucker, S. L., Richon, V. M., & Meyn, R. E. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0022 · Cited by 219
Genetic Alterations and Oncogenic Pathways Associated with Breast Cancer Subtypes
Hu, X., Stern, H. M., Ge, L., O'Brien, C., Haydu, L., Honchell, C. D., Haverty, P. M., Peters, B. A., Wu, T. D., Amler, L. C., et al. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0107 · Cited by 217
Belinostat: First Global Approval
Poole, R. M. (2014) · Drugs · doi:10.1007/s40265-014-0275-8 · Cited by 216
Manuyakorn, A., Paulus, R., Farrell, J., Dawson, N. A., Tze, S., Cheung-Lau, G., Hines, O. J., Reber, H., Seligson, D. B., Horvath, S., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.5639 · Cited by 216
Panobinostat: First Global Approval
Garnock-Jones, K. P. (2015) · Drugs · doi:10.1007/s40265-015-0388-8 · Cited by 212
Histone ubiquitination in the DNA damage response
Uckelmann, M., & Sixma, T. K. (2017) · DNA Repair · doi:10.1016/j.dnarep.2017.06.011 · Cited by 212
JARID1B Is a Luminal Lineage-Driving Oncogene in Breast Cancer
Yamamoto, S., Wu, Z., Russnes, H. G., Takagi, S., Peluffo, G., Vaske, C., Zhao, X., Moen Vollan, H. K., Maruyama, R., Ekram, M. B., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.024 · Cited by 207
Hayami, S., Yoshimatsu, M., Veerakumarasivam, A., Unoki, M., Iwai, Y., Tsunoda, T., Field, H. I., Kelly, J. D., Neal, D. E., Yamaue, H., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-59 · Cited by 207
A Peek into the Complex Realm of Histone Phosphorylation
Banerjee, T., & Chakravarti, D. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05631-11 · Cited by 206
Beyond histone acetylation—writing and erasing histone acylations
Zhao, S., Zhang, X., & Li, H. (2018) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2018.10.001 · Cited by 206
Proteasomal ATPases Link Ubiquitylation of Histone H2B to Methylation of Histone H3
Ezhkova, E., & Tansey, W. P. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00026-7 · Cited by 205
Histone propionylation is a mark of active chromatin
Kebede, A. F., Nieborak, A., Shahidian, L. Z., Le Gras, S., Richter, F., Gómez, D. A., Baltissen, M. P., Meszaros, G., Magliarelli, H. D. F., Taudt, A., et al. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3490 · Cited by 205
N-Lysine Propionylation Controls the Activity of Propionyl-CoA Synthetase
Garrity, J., Gardner, J. G., Hawse, W., Wolberger, C., & Escalante-Semerena, J. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704409200 · Cited by 203
Mishima, Y., Miyagi, S., Saraya, A., Negishi, M., Endoh, M., Endo, T. A., Toyoda, T., Shinga, J., Katsumoto, T., Chiba, T., et al. (2011) · Blood · doi:10.1182/blood-2011-01-331892 · Cited by 198
Histone H2A phosphorylation in DNA double‐strand break repair
Foster, E. R., & Downs, J. A. (2005) · The FEBS Journal · doi:10.1111/j.1742-4658.2005.04741.x · Cited by 194
Novel mitosis-specific phosphorylation of histone H3 at Thr11 mediated by Dlk/ZIP kinase
Preuss, U. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg176 · Cited by 190
Targeting histone lysine methylation in cancer
McGrath, J., & Trojer, P. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.01.002 · Cited by 186
Huang, S., Wang, Z., Zhou, J., Huang, J., Zhou, L., Luo, J., Wan, Y. Y., Long, H., & Zhu, B. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2395 · Cited by 185
Structure of a Biologically Active Estrogen Receptor-Coactivator Complex on DNA
Yi, P., Wang, Z., Feng, Q., Pintilie, G. D., Foulds, C. E., Lanz, R. B., Ludtke, S. J., Schmid, M. F., Chiu, W., & O’Malley, B. W. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.01.025 · Cited by 184
Lysine acetylation and cancer: A proteomics perspective
Gil, J., Ramírez-Torres, A., & Encarnación-Guevara, S. (2017) · Journal of Proteomics · doi:10.1016/j.jprot.2016.10.003 · Cited by 184
Protein-Based Inheritance: Epigenetics beyond the Chromosome
Harvey, Z. H., Chen, Y., & Jarosz, D. F. (2018) · Molecular Cell · doi:10.1016/j.molcel.2017.10.030 · Cited by 183
Park, Y. S., Jin, M. Y., Kim, Y. J., Yook, J. H., Kim, B. S., & Jang, S. J. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-9927-9 · Cited by 182
Metabolites Regulate Cell Signaling and Growth via Covalent Modification of Proteins
Figlia, G., Willnow, P., & Teleman, A. A. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.06.036 · Cited by 182
The role and mechanism of histone lactylation in health and diseases
Xie, Y., Hu, H., Liu, M., Zhou, T., Cheng, X., Huang, W., & Cao, L. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.949252 · Cited by 181
Exchange of associated factors directs a switch in HBO1 acetyltransferase histone tail specificity
Lalonde, M.-E., Avvakumov, N., Glass, K. C., Joncas, F.-H., Saksouk, N., Holliday, M., Paquet, E., Yan, K., Tong, Q., Klein, B. J., et al. (2013) · Genes & Development · doi:10.1101/gad.223396.113 · Cited by 179
Epigenetic Modifications in Double-Strand Break DNA Damage Signaling and Repair
Rossetto, D., Truman, A. W., Kron, S. J., & Côté, J. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0513 · Cited by 176
CircMRPS35 suppresses gastric cancer progression via recruiting KAT7 to govern histone modification
Jie, M., Wu, Y., Gao, M., Li, X., Liu, C., Ouyang, Q., Tang, Q., Shan, C., Lv, Y., Zhang, K., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01160-2 · Cited by 176
LSD1-mediated epigenetic modification contributes to proliferation and metastasis of colon cancer
Ding, J., Zhang, Z.-M., Xia, Y., Liao, G.-Q., Pan, Y., Liu, S., Zhang, Y., & Yan, Z.-S. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.364 · Cited by 175
Targeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid Leukemia
Cheung, N., Fung, T. K., Zeisig, B. B., Holmes, K., Rane, J. K., Mowen, K. A., Finn, M. G., Lenhard, B., Chan, L. C., & So, C. W. E. (2016) · Cancer Cell · doi:10.1016/j.ccell.2015.12.007 · Cited by 175
Jones, C. L., Sheth, A. I., & Jordan, C. T. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.02.013 · Cited by 172
Liu, X., Wei, W., Liu, Y., Yang, X., Wu, J., Zhang, Y., Zhang, Q., Shi, T., Du, J. X., Zhao, Y., et al. (2017) · Cell Discovery · doi:10.1038/celldisc.2017.16 · Cited by 171
Self-citationHDAC inhibitors: Targets for tumor therapy, immune modulation and lung diseases
Shanmugam, G., Rakshit, S., & Sarkar, K. (2022) · Translational Oncology · doi:10.1016/j.tranon.2021.101312 · Cited by 171
Polycomb group-mediated histone H2A monoubiquitination in epigenome regulation and nuclear processes
Barbour, H., Daou, S., Hendzel, M. J., & Affar, E. B. (2020) · Nature Communications · doi:10.1038/s41467-020-19722-9 · Cited by 170
Tarighat, S. S., Santhanam, R., Frankhouser, D., Radomska, H. S., Lai, H., Anghelina, M., Wang, H., Huang, X., Alinari, L., Walker, A., et al. (2016) · Leukemia · doi:10.1038/leu.2015.308 · Cited by 169
Histone methyltransferase SETDB1 regulates liver cancer cell growth through methylation of p53
Fei, Q., Shang, K., Zhang, J., Chuai, S., Kong, D., Zhou, T., Fu, S., Liang, Y., Li, C., Chen, Z., et al. (2015) · Nature Communications · doi:10.1038/ncomms9651 · Cited by 169
AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway
Chen, T., Dai, X., Dai, J., Ding, C., Zhang, Z., Lin, Z., Hu, J., Lu, M., Wang, Z., Qi, Y., et al. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-03030-7 · Cited by 168
Izutsu, K., Makita, S., Nosaka, K., Yoshimitsu, M., Utsunomiya, A., Kusumoto, S., Morishima, S., Tsukasaki, K., Kawamata, T., Ono, T., et al. (2023) · Blood · doi:10.1182/blood.2022016862 · Cited by 167
HBO1 is required for the maintenance of leukaemia stem cells
MacPherson, L., Anokye, J., Yeung, M. M., Lam, E. Y. N., Chan, Y.-C., Weng, C.-F., Yeh, P., Knezevic, K., Butler, M. S., Hoegl, A., et al. (2020) · Nature · doi:10.1038/s41586-019-1835-6 · Cited by 167
Wei, L., Chiu, D. K.-C., Tsang, F. H.-C., Law, C.-T., Cheng, C. L.-H., Au, S. L.-K., Lee, J. M.-F., Wong, C. C.-L., Ng, I. O.-L., & Wong, C.-M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.015 · Cited by 163
Understanding the Function of Mammalian Sirtuins and Protein Lysine Acylation
Wang, M., & Lin, H. (2021) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-082520-125411 · Cited by 161
Prenzel, T., Begus-Nahrmann, Y., Kramer, F., Hennion, M., Hsu, C., Gorsler, T., Hintermair, C., Eick, D., Kremmer, E., Simons, M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1896 · Cited by 160
Emerging Role of Ubiquitination in the Regulation of PD-1/PD-L1 in Cancer Immunotherapy
Hu, X., Wang, J., Chu, M., Liu, Y., Wang, Z. P., & Zhu, X. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.032 · Cited by 159
Quintás‐Cardama, A., Santos, F. P. D. S., & Garcia‐Manero, G. (2010) · Leukemia · doi:10.1038/leu.2010.276 · Cited by 156
Histone modifications as markers of cancer prognosis: a cellular view
Kurdistani, S. K. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603844 · Cited by 156
A vaccine targeting resistant tumours by dual T cell plus NK cell attack
Badrinath, S., Dellacherie, M. O., Li, A. W., Zheng, S., Zhang, X., Sobral, M. C., Pyrdol, J. W., Smith, K. L., Lu, Y., Haag, S., et al. (2022) · Nature · doi:10.1038/s41586-022-04772-4 · Cited by 155
Self-citationZhang, K., Chen, Y., Zhang, Z., & Zhao, Y. (2008) · Journal of Proteome Research · doi:10.1021/pr8005155 · Cited by 154
Identification and Characterization of Propionylation at Histone H3 Lysine 23 in Mammalian Cells
Liu, B., Lin, Y.-H., Darwanto, A., Song, X., Xu, G., & Zhang, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.045856 · Cited by 153
The Role of Histone Acetyltransferases in Normal and Malignant Hematopoiesis
Sun, X., Man, N., Tan, Y., Nimer, S. D., & Wang, L. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00108 · Cited by 152
Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors
Singh, M. M., Manton, C. A., Bhat, K., Tsai, W.-W., Aldape, K., Barton, M. C., & Chandra, J. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor049 · Cited by 152
Protein Acetylation in Bacteria
VanDrisse, C. M., & Escalante‐Semerena, J. C. (2019) · Annual Review of Microbiology · doi:10.1146/annurev-micro-020518-115526 · Cited by 151
Dichotomous engagement of HDAC3 activity governs inflammatory responses
Nguyen, H. C. B., Adlanmerini, M., Hauck, A. K., & Lazar, M. A. (2020) · Nature · doi:10.1038/s41586-020-2576-2 · Cited by 150
Quantitative Sub-Cellular Acyl-Coa Analysis Reveals Distinct Nuclear Regulation
Trefely, S., Huber, K., Liu, J., Noji, M., Stransky, S., Singh, J. P., Doan, M. T., Lovell, C. D., von Krusenstiern, E. V., Jiang, H., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.11.006 · Cited by 145
Functions and mechanisms of lysine crotonylation
Wan, J., Liu, H., Chu, J., & Zhang, H. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14650 · Cited by 143
Self-citationPérez-Cadahı́a, B., Drobic, B., & Davie, J. (2009) · Biochemistry and Cell Biology · doi:10.1139/o09-053 · Cited by 141
Yao, B., Gui, T., Zeng, X., Deng, Y., Wang, Z., Wang, Y., Yang, D., Li, Q., Xu, P., Hu, R., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00871-5 · Cited by 140
Global Histone H4 Acetylation and HDAC2 Expression in Colon Adenoma and Carcinoma
Ashktorab, H., Belgrave, K., Hosseinkhah, F., Brim, H., Nouraie, M. S., Takkikto, M., Hewitt, S. M., Lee, E. L., Dashwood, R. H., & Smoot, D. T. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0601-7 · Cited by 139
Bitzer, M., Horger, M., Giannini, E. G., Ganten, T. M., Wörns, M., Siveke, J. T., Dollinger, M., Gerken, G., Scheulen, M. E., Wege, H., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.043 · Cited by 139
Kelly, R. D. W., Chandru, A., Watson, P. J., Song, Y., Blades, M., Robertson, N. S., Jamieson, A. G., Schwabe, J. W. R., & Cowley, S. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-32927-9 · Cited by 138
Antitumor activity of a small-molecule inhibitor of the histone kinase Haspin
Huertas, D., Soler, M., Moretó, J., Villanueva, A., Martı́nez, A., Vidal, A., Charlton, M., Moffat, D., Patel, S. A., McDermott, J., et al. (2011) · Oncogene · doi:10.1038/onc.2011.335 · Cited by 137
Du, Y., Cai, T., Li, T., Xue, P., Zhou, B., He, X., Peng, W., Liu, P., Yang, F., & Wei, T. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.041947 · Cited by 135
Romidepsin for the Treatment of Peripheral T-Cell Lymphoma
Iyer, S. P., & Foss, F. M. (2015) · The Oncologist · doi:10.1634/theoncologist.2015-0043 · Cited by 134
Kamada, R., Kudoh, F., Ito, S., Tani, I., Janairo, J. I. B., Omichinski, J. G., & Sakaguchi, K. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107622 · Cited by 133
Epigenetics in ovarian cancer: premise, properties, and perspectives
Yang, Q., Yang, Y., Zhou, N., Tang, K., Lau, W. B., Lau, B., Wang, W., Xu, L., Yang, Z., Huang, S., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0855-4 · Cited by 131
A SMYD3 Small‐Molecule Inhibitor Impairing Cancer Cell Growth
Peserico, A., Germani, A., Sanese, P., Barbosa, A. J. M., Virgilio, V. D., Fittipaldi, R., Fabini, E., Bertucci, C., Varchi, G., Moyer, M. P., et al. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24975 · Cited by 128
Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy
Komar, D. N., & Juszczyński, P. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00941-2 · Cited by 128
HDAC3 overexpression and colon cancer cell proliferation and differentiation
Spurling, C. C., Godman, C. A., Noonan, E. J., Rasmussen, T. P., Rosenberg, D. W., & Giardina, C. A. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20373 · Cited by 127
Yamashita, K., Shinohara, M., & Shinohara, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400078101 · Cited by 124
Bamodu, O. A., Huang, W.-C., Lee, W., Wu, A. T. H., Wang, L. S., Hsiao, M., Yeh, C., & Chao, T.-Y. (2016) · BMC Cancer · doi:10.1186/s12885-016-2108-5 · Cited by 122
KDM5B is a master regulator of the H3K4-methylome in stem cells, development and cancer
Xhabija, B., & Kidder, B. L. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.11.001 · Cited by 121
Cusan, M., Cai, S. F., Mohammad, H. P., Krivtsov, A. V., Chramiec, A. G., Loizou, E., Witkin, M. D., Smitheman, K. N., Tenen, D. G., Ye, M., et al. (2018) · Blood · doi:10.1182/blood-2017-09-807024 · Cited by 120
Hidden pharmacological activities of valproic acid: A new insight
Singh, D., Gupta, S., Verma, I., Morsy, M. A., Nair, A. B., & Ahmed, A. F. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112021 · Cited by 119
Seidlitz, T., Koo, B., & Stange, D. E. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00662-2 · Cited by 118
Montellier, E., Rousseaux, S., Zhao, Y., & Khochbin, S. (2012) · BioEssays · doi:10.1002/bies.201100141 · Cited by 116
Histone Methyltransferase SETDB1: A Common Denominator of Tumorigenesis with Therapeutic Potential
Strepkos, D., Markouli, M., Κλώνου, Α., Papavassiliou, A. G., & Piperi, C. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-2906 · Cited by 116
Benard, A., Goossens-Beumer, I. J., van Hoesel, A. Q., de Graaf, W., Horati, H., Putter, H., Zeestraten, E. C. M., van de Velde, C. J., & Kuppen, P. J. K. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-531 · Cited by 115
Roles of lysine-specific demethylase 1 (LSD1) in homeostasis and diseases
Kim, D., Kim, K. I., & Baek, S. H. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00737-3 · Cited by 115
Cao, C., Vasilatos, S. N., Bhargava, R., Fine, J. L., Oesterreich, S., Davidson, N. E., & Huang, Y. (2016) · Oncogene · doi:10.1038/onc.2016.186 · Cited by 114
Regulation of the Dot1 histone H3K79 methyltransferase by histone H4K16 acetylation
Valencia‐Sánchez, M. I., Ioannes, P. D., Wang, M., Truong, D. M., Lee, R., Armache, J., Boeke, J. D., & Armache, K. (2021) · Science · doi:10.1126/science.abc6663 · Cited by 114
Targeting post-translational histone modifying enzymes in glioblastoma
Kunadis, E., Lakiotaki, E., Korkolopoulou, P. A., & Piperi, C. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107721 · Cited by 113
Avvakumov, N., Lalonde, M., Saksouk, N., Paquet, É. R., Glass, K. C., Landry, A.-J., Doyon, Y., Cayrou, C., Robitaille, G., Richard, D. E., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.06455-11 · Cited by 112
Lysine crotonylation is involved in hepatocellular carcinoma progression
Wan, J., Liu, H., & Ming, L. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.148 · Cited by 112
Crump, N. T., Hazzalin, C. A., Bowers, E. M., Alani, R. M., Cole, P. A., & Mahadevan, L. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100099108 · Cited by 111
Genomic targets, and histone acetylation and gene expression profiling of neural HDAC inhibition
López‐Atalaya, J. P., Ito, S., Valor, L. M., Benito, E., & Barco, Á. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt590 · Cited by 111
The Discovery of Histone DemethylasesPreprint
Shi, Y. G., & Tsukada, Y.-I. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a017947 · Cited by 111
Slaughter, M. J., Shanle, E. K., Khan, A. A., Chua, K. F., Hong, T., Boxer, L. D., Allis, C. D., Josefowicz, S. Z., Garcia, B. A., Rothbart, S. B., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108638 · Cited by 110
Wang, T., Zhang, H., Qiu, W., Han, Y., Liu, H., & Li, Z. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.12.029 · Cited by 110
Self-citationH3K36me3, message from chromatin to DNA damage repair
Sun, Z., Zhang, Y., Jia, J., Fang, Y., Tang, Y., Wu, H., & Fang, D. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-0374-z · Cited by 109
Abbosh, P. H., Montgomery, J. S., Starkey, J. A., Novotný, M. V., Zuhowski, E. G., Egorin, M. J., Moseman, A. P., Golas, A. A., Brannon, K. M., Balch, C., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3575 · Cited by 109
Histone H3 lysine 27 acetylation is altered in colon cancer
Karczmarski, J., Rubel, T., Paziewska, A., Mikuła, M., Bujko, M., Kober, P., Dadlez, M., & Ostrowski, J. (2014) · Clinical Proteomics · doi:10.1186/1559-0275-11-24 · Cited by 108
Protein N-Terminal Acetylation: Structural Basis, Mechanism, Versatility, and Regulation
Deng, S., & Marmorstein, R. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.08.005 · Cited by 108
M6A RNA Methylation Regulates Histone Ubiquitination to Support Cancer Growth and Progression
Yadav, P., Subbarayalu, P., Medina, D., Nirzhor, S. S. R., Timilsina, S., Rajamanickam, S., Eedunuri, V. K., Gupta, Y. K., Zheng, S., Abdelfattah, N., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-2106 · Cited by 108
Song, J. S., Kim, Y. S., Kim, D. K., Park, S. I., & Jang, S. J. (2012) · Pathology International · doi:10.1111/j.1440-1827.2011.02776.x · Cited by 103
The noncanonical role of EZH2 in cancer
Huang, J., Gou, H., Yao, J., Yi, K., Jin, Z., Matsuoka, M., & Zhao, T. (2021) · Cancer Science · doi:10.1111/cas.14840 · Cited by 102
PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD+ acute myeloid leukemia
He, X., Zhu, Y., Lin, Y., Li, M., Du, J., Dong, H., Sun, J., Zhu, L., Wang, H., Ding, Z., et al. (2019) · Blood · doi:10.1182/blood.2019001282 · Cited by 101
Self-citationAn, W., Palhan, V. B., Karymov, M. A., Leuba, S. H., & Roeder, R. G. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00497-5 · Cited by 100
Zhang, Z.-G., Zhang, H., Sun, H., Liu, H.-Y., Liu, M.-Y., & Zhou, Z. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.04.006 · Cited by 100
Self-citationH2B Tyr37 phosphorylation suppresses expression of replication-dependent core histone genes
Mahajan, K. N., Fang, B., Koomen, J. M., & Mahajan, N. P. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2356 · Cited by 99
Role for Plk1 phosphorylation of Hbo1 in regulation of replication licensing
Wu, Z.-Q., & Liu, X. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712063105 · Cited by 99
BMI1 and Mel-18 oppositely regulate carcinogenesis and progression of gastric cancer
Zhang, X.-W., Sheng, Y.-P., Li, Q., Qin, W., Lu, Y.-W., Cheng, Y., Liu, B., Zhang, F. C., Li, J., Dimri, G. P., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-40 · Cited by 99
Self-citationLane, S., & Gilliland, D. G. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.12.001 · Cited by 98
Oike, T., Komachi, M., Ogiwara, H., Amornwichet, N., Saitoh, Y., Torikai, K., Kubo, N., Nakano, T., & Kohno, T. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.03.015 · Cited by 98
Recent Advances in the Therapeutic Strategies of Glioblastoma Multiforme
Aldoghachi, A. F., Aldoghachi, A. F., Breyne, K., Ling, K., & Cheah, P.-S. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.03.030 · Cited by 98
Plk1 Phosphorylation of Orc2 and Hbo1 Contributes to Gemcitabine Resistance in Pancreatic Cancer
Song, B., Liu, X. S., Rice, S. J., Kuang, S., Elzey, B. D., Konieczny, S. F., Ratliff, T. L., Hazbun, T. R., Chiorean, E. G., & Liu, X. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0632 · Cited by 97
Cited by
Acetylation of histone H3 in cancer progression and prognosis
Miziak, P., Baran, M., Borkiewicz, L., Trombik, T., & Stepulak, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010982 · Cited by 49
Kamrani, S., Naseramini, R., Khani, P., Razavi, Z. S., Afkhami, H., Atashzar, M. R., Nasri, F., Alavimanesh, S., Saeidi, F., & Ronaghi, H. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03741-x · Cited by 27
Metadata
- Authors
- Liu, R., Wu, J., Guo, H., Yao, W., Li, S., Lu, Y., Jia, Y., Liang, X., Tang, J., & Zhang, H.
- Venue
- MedComm
- Publisher
- Wiley
- Published
- 2023-05-20
- Volume
- 4
- Issue
- 3
- Pages
- e292-e292
- ISSN
- 2688-2663 (ISSN-L)
- OpenAlex
- W4377205881
- Cited by
- 264
- References
- 389
- FWCI
- 19.65
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.